Orthofix Medical (OFIX) Gross Profit (2010 - 2026)

Orthofix Medical has disclosed Gross Profit across 17 years of filings, most recently posting $139.5 million for Q1 2026.

• Quarterly Gross Profit rose 14.74% year-over-year to $139.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $583.9 million (up 8.09% YoY) and the FY2025 annual result came in at $566.0 million, up 3.69% from the prior year.
• Gross Profit eased to $139.5 million in Q1 2026, from $156.3 million in the prior quarter.
• Over five years, Gross Profit peaked at $156.3 million in Q4 2025 and troughed at $78.1 million in Q1 2022.
• A 5-year average of $122.1 million and a median of $127.2 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit decreased 7.97% — and 2023, when it surged 53.21%.
• Tracing OFIX's Gross Profit over 5 years: stood at $89.2 million in 2022, then soared by 53.21% to $136.6 million in 2023, then increased by 8.94% to $148.8 million in 2024, then advanced by 5.04% to $156.3 million in 2025, then dropped by 10.74% to $139.5 million in 2026.
• Business Quant data shows OFIX's Gross Profit at $139.5 million in Q1 2026, $156.3 million in Q4 2025, and $148.5 million in Q3 2025.